Anaesthetic Challenges in Management of Patient of Insulinoma

Vol 5 | Issue 3 | Sep-Dec 2019 | page: 24-27  | Reshma S Pharande, Vinaya Kulkarni, Rohit Sancheti, Sunita Khedkar


Authors: Reshma S Pharande [1], Vinaya Kulkarni [1], Rohit Sancheti [1], Sunita Khedkar [1]

Address of Correspondence
Dr. Vinaya Kulkarni,

Department of Anaesthesia, BJGMC, Pune, Maharashtra, India
E-mail: vinayabjmc@yahoo.com

1 Department of Anaesthesia, BJGMC, Pune.


Introduction: Insulinoma is a rare neuroendocrine tumor of the pancreas that produces symptoms due to hypersecretion of insulin from β-cells. They are often misdiagnosed or have delayed diagnosis due to their bizarre clinical presentation. Diagnosis is made based on history (Whipple’s triad), biochemical tests and imaging modalities. Surgical resection is the curative treatment. General anaesthesia is an ideal technique as it reduces the cerebral metabolism and oxygen consumption. We present a case of an 45 year old female patient diagnosed with insulinoma who had history of recurrent hypoglycemic attacks. Surgical enucleation of the tumor was undertaken. Perioperative management of blood sugar in these patients is of utmost importance. As anaesthesiologist our target is to prevent severe hypoglycemic episodes which may lead to permanent neurological damage and severe hyperglycemia post procedure which has to be managed by titrating the dose of insulin and dextrose.
Keywords: Insulinoma, Anaesthetic management, Hypoglycemia, Surgical excision, Neuroendocrine tumors


References

1. Service FJ, McMohan MM, O’Brein PC, Ballard DJ. Functioning insulinoma – incidence, recurrence & long term survival of patients: a 60 year study. Mayo Clin Proc. 1991 Jul;66 (7):711-9.
2. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN (2010) Pancreatic insulinomas: Current issues and trends. HepatobiliaryPancreat Dis Int 9(3): 234- 241.
3. Tucker ON, Crotty PL, Conlon KC (2006) The management of insulinoma. Br J Surg 93(3): 264-275
4. Abboud B, Boujaoude J (2005) Occult sporadic insulinoma: Localization and surgical strategy. World J Gastroenterol 14(5): 657-665.
5. Abboud B, Boujaoude J. Occult sporadic insulinoma: localization and surgical strategy. World J Gastroenterol. 2008;14:657–65.
6. Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am. 1999;28:495–500, v–vi.
7. Bouslama K, Maghrebi H, Bedioui H, Bouslama K. Pancreatic insulinoma: diagnostic approach and therapeutic modalities. J Afr Hépatol Gastroentérol. 2014;8:11–5.
8. Goswami J, Somkuwar P, Naik Y (2012) Insulinoma and anaesthetici mplications. Indian J Anaesthesia 56(2): 117-122.
9. Whipple AO, Frantz VK (1935) Adenoma of islet cells with hyperinsulinism: A review. Ann Surg 101(6):1299-335.
10. Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829–37.
11. Desborough JP, Hall GM, Hart GR, Burrin JM. Midazolam modifies pancreatic and anterior pituitary hormone secretion during upper abdominal surgery. Br J Anesth 1991;67:390-6.
12. Ishii H, Arai T, Segawa H, Morikawa S, Inubushi T, Fukuda K. Effects of propofol on lactate accumulation and oedema formation in focal cerebral ischaemia in hyperglycaemic rats. Br J Anaesth 2002;88:412-7.
13. Zhu M, Chen J, Jiang H, Miao C. Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc Diabetol 2013;12:13.
14. David JS, Tavernier B, Amour J, Vivien B, Coriat P, Riou B. Myocardial effects of halothane and sevoflurane in diabetic rats. Anesthesiology 2004;100:1179-87.
15. Walsh ES, Traynor C, Paterson JL, Hall GM. Effect of different intraoperative fluid regimens on circulating metabolites and insulin during abdominal surgery. Br J Anaesth., 1983; 55: 135–40.
16. Chin KJ, Macachor J, Ong KC, Ong BC. A comparison of 5% dextrose in 0.9% normal saline versus non-dextrosecontaining crystalloids as the initial intravenous replacement fluid in elective surgery. Anaesth Intensive Care, 2006; 34: 613–7.
17. Azarfarin R, Alizadeh Asl A. Prevalence and intensity of hyperglycemia in nondiabetic patients undergoing coronary artery bypass graft surgery with and without cardiopulmonary bypass. Saudi Med J., 2008; 29: 1294–8.
18. Saringcarinkul A, Kotrawera K. Plasma glucose level in elective surgical patients administered with 5% dextrose in 0.45% NaCl in comparison with those receiving lactated Ringer’s solution. J Med Assoc Thai., 2009; 92: 1178–83.
19. Lattermann R, Carli F, Wykes L, Schricker T. Epidural blockade modifies perioperative glucose production without affecting protein catabolism. Anesthesiology 2002;97:374-81.
20. Lattermann R, Carli F, Wykes L, Schricker T. Perioperative glucose infusion and the catabolic response to surgery: the effect of epidural block. Anesth Analg 2003;96:555-62.
21. Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management & controversies. Cancer. 2008 Oct 1;113(7 Suppl):1807-43.
22. Grant CS.Insulinoma. Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):783-98.
23. Arnold R, Weid M, Behr TH. Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract. Expert Opin Pharmacother. 2002 Jun;3(6):643-56.


How to Cite this Article:Pharande R S, Kulkarni V, Sancheti R, Khedkar S | Anaesthetic Challenges in Management of Patient of Insulinoma | Journal of Anaesthesia and Critical Care Case Reports | Sep – Dec 2019; 5(3): 24-27.

 


(Abstract) (Full Text HTML)      (Download PDF)


.